Carlsmed Reports Q1 2026 Earnings with 58% Revenue Growth and Surge in Surgeon Users
Carlsmed (CARL) reported Q1 2026 earnings with revenue of $16.1 million, a 58% year-over-year increase driven by surgeon user base expansion and higher procedure volume. The company's gross margin improved to 77.1%, up 220 basis points, but operating expenses rose to $21.7 million, contributing to a GAAP net loss of $8.7 million. Carlsmed also reduced production lead time by over 30% and maintained $97.1 million in cash and investments.
Topics: cash_balance debt ebitda gross_margin operating_expenses revenue user_growth